Ticarcillin Disodium/Clavulanate Potassium

替卡西林钠/克拉维酸钾

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTicarcillin Disodium/Clavulanate Potassium
Drug Alias Name替卡西林/克拉维酸Ticarcillin Disodium and Clavulanate PotassiumTicarcillin Disodium•Clavulanate Potassium替卡西林克拉维酸钾替卡西林钠/克拉维酸 +[12] 
ClassificationSmall molecules
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[7] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1985/04/01
Country/TerritoryUnited StatesMainland China
CombinationsYes Ticarcillin Disodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesSmithkline Beecham Pharmaceuticals
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsBacterial Infections
Inactive IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[6] 

Other Information

ATC CodeJ01CR03
Related LinksWikipediaKEGG